Nineteen individuals from the Mount Sinai Health System were honored for their contributions to research, technology, medicine, and health care at the second annual Mount Sinai Innovation Awards ceremony, which was held on Monday, October 24, in conjunction with the SinaInnovations conference. (more…)
Alison M. Goate, DPhil
Two prominent researchers at the Icahn School of Medicine at Mount Sinai, Alison M. Goate, DPhil, and Lynne D. Richardson, MD, recently were elected to the prestigious National Academy of Medicine, formerly named the Institute of Medicine. Dr. Goate is the Willard T.C. Johnson Research Professor of Neurogenetics, and Director of the Ronald M. Loeb Center on Alzheimer’s Disease. Dr. Richardson is Professor and Vice Chair of Emergency Medicine, and Professor of Population Health Science and Policy. (more…)
For more than 20 years, the Department of Medicine has organized a lecture series focused on ethics and the compassionate care of patients. This year, the Alexander Richman Commemorative Award and Lecture in Humanism and Ethics began a new and integrative approach to expand its scope. (more…)
Hélène Salmon, PhD
Hélène Salmon, PhD, and Lara Manganaro, PhD, are the recipients of the 2016 Robin Chemers Neustein Postdoctoral Fellowship Award, which was created to encourage and support female research scientists at the Icahn School of Medicine at Mount Sinai. (more…)
Many people who are exposed to second-hand cigarette smoke on a day-to-day basis do not realize it, according to newly published research by physicians at the Icahn School of Medicine at Mount Sinai. Yet exposure to this carcinogen carries an increased risk for heart disease and lung cancer, and mortality by an average of three years, exceeding even that of former smokers who are not exposed.
These were among the findings reported by Raja M. Flores, MD, and Emanuela Taioli, MD, PhD, in a study that appeared in the October issue of Carcinogenesis. (more…)
Study researchers Jean-Frédéric Colombel, MD, and Joana Torres, MD, postdoctoral fellow, Department of Medicine (Gastroenterology)
Years before inflammatory bowel disease (IBD) is diagnosed and symptoms exist, biomarkers are already circulating that can help predict risk not only of disease development but also of complications, according to recent findings by Mount Sinai scientists and partner organizations. For the first time, researchers found that these markers, in the form of antimicrobial antibodies, were present in serum up to six years before diagnosis of IBD, and that the higher number of antibodies indicated a greater chance of complications at or around the time of diagnosis. (more…)